LifeStance Health Group, Inc. (LFST) is an innovative health care service firm, primarily focused on providing mental health services for people of all ages. Headquartered in Scottsdale, Arizona, the company was founded on the fundamental belief that understanding and compassion are at the heart of wellness.
LifeStance Health Group, Inc. operates nationwide across the United States, with a vast network of behavioral health clinics. It is recognized for providing a varied range of services like psychiatry, psychotherapy, and counselling. The company caters to numerous psychological or psychiatric conditions such as anxiety, depression, obsessive-compulsive disorder (OCD), attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), and many more. The incredibly rich diversity in the types of services it offers, unequivocally, differentiates LifeStance Health Group, Inc. from its competitors.
Professionally, LifeStance Health Group, Inc. is home to more than 3,300 licensed mental health professionals. This includes psychiatrists, psychologists, nurse practitioners, and licensed therapists, committed to delivering compassionate, patient-focused care. Taking pride in their integrated, team-based approach that pairs a patient with the appropriate clinician, based on the patient’s specific needs and preferences, LifeStance indeed sets a high standard for personalized mental health care.
Moreover, LifeStance Health Group, Inc. acknowledges the steep rise in demand for mental health services over the past years; thus, they have employed a flexible service model that allows for both in-person visits and telehealth sessions. This not only makes mental health services more accessible but also ensures that individuals can receive professional help in a way that best suits their needs.
Externally, LifeStance Health Group went public in June 2021, trading under LFST on NASDAQ. This development was important in this sector. Going public reflects the substantial growth of this group and its intent to expand its accessible and high-quality psychological services further.
In conclusion, LifeStance Health Group, Inc. is more than just a healthcare service company. With its dedication to a mission to help people lead healthier, more fulfilling lives through a patient-centric, evidence-based approach to mental health, it also stands as a beacon of resolve in an increasingly stressful world. Supporting people and communities in achieving optimal mental health are at the core of its operations and its commitment to driving positive change in mental healthcare.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Analysts have increased their price target for LifeStance Health Group (LFST) to $14.20, driven by updated assumptions for revenue growth, profit margins, and future P/E ratios. The company reported strong Q2 results with revenue up 26.1% year-on-year, exceeding expectations, and announced a share repurchase agreement, further strengthening its financial outlook. Despite a secondary public offering by existing stockholders, the company's raised EBITDA guidance and share buybacks are viewed positively.
LifeStance Health Group's CTO, Vukasin Paunovich, sold 42,067 shares worth over $541,000 on September 2, 2026. Despite the sale, Paunovich retains 205,379 shares, and the transaction is considered routine given the company's stock price has surged 134.5% over the past year. Analysts suggest this sale does not indicate a negative outlook for the company but rather an insider taking profits.
LifeStance Health Group, a major provider of mental health care, announced the pricing of a secondary public offering of 22,250,000 shares of its common stock at $12.35 per share. The offering is by certain selling stockholders, meaning LifeStance will not receive any proceeds from the sale. However, the company has agreed to repurchase 2,000,000 shares from the underwriter.
_07_03_2026_03_50_21_133108.jpg)
LifeStance Health Group CEO Bourdon David acquired 150,000 shares at no cost in a code-J transaction on September 2, 2026. This transaction increased his total reported ownership to 1,248,247 shares. The update provides investors with insight into his equity stake in the company.
LifeStance Health Foundation has renewed its partnership with the American Foundation for Suicide Prevention (AFSP), committing $100,000 to support clinical research aimed at advancing suicide prevention strategies. This renewed collaboration builds on a successful inaugural year where LifeStance contributed over $170,000 to AFSP's initiatives. The partnership emphasizes the critical need for continued research to address the urgent public health crisis of suicide, which claimed 48,824 lives in 2024.